{
  "$schema": "folio-library-entry/v1",
  "id": "10665-42988",
  "blocks": [
    {
      "id": "library/10665-42988/blocks/figure-img-p001-2",
      "types": [
        "folio-assistant-core:Figure",
        "doco:Figure"
      ],
      "kind": "figure",
      "title": "",
      "pageStart": 1,
      "pageEnd": 1,
      "target": "../images/img-p001-2.webp",
      "narrative": "draft",
      "content": "Blue-toned cover photograph of a young child, mouth open, receiving drops of oral vaccine from a dropper held by an adult's hand, with other people blurred in the background.",
      "truncated": false,
      "provenance": "ingested",
      "summary": null
    },
    {
      "id": "library/10665-42988/blocks/prose-page-001",
      "types": [
        "folio-assistant-core:Prose",
        "doco:Section"
      ],
      "kind": "prose",
      "title": "Page 1",
      "pageStart": 1,
      "pageEnd": 1,
      "target": "../sections/page-001.md",
      "narrative": null,
      "content": "Plan stratégique de l'Initiative mondiale\npour l’éradication de la poliomyélite\n2004–2008\nOMS\nPartenaires de l’Initiative mondiale pour l’éradication de la poliomyélite",
      "truncated": false,
      "provenance": "ingested",
      "summary": {
        "status": "draft",
        "text": "The cover page of the French edition of the Global Polio Eradication Initiative Strategic Plan 2004–2008, issued by WHO and the initiative's partners.",
        "state": "draft",
        "draftedBy": {
          "kind": "agent",
          "id": "claude-code",
          "model": "not-disclosed"
        },
        "draftedAt": "2026-11-11"
      }
    },
    {
      "id": "library/10665-42988/blocks/prose-page-002",
      "types": [
        "folio-assistant-core:Prose",
        "doco:Section"
      ],
      "kind": "prose",
      "title": "Page 2",
      "pageStart": 2,
      "pageEnd": 2,
      "target": "../sections/page-002.md",
      "narrative": null,
      "content": "Catalogage à la source : Bibliothèque de l’OMS\nInitiative mondiale pour l'éradication de la poliomyélite.\nPlan stratégique de l'Initiative mondiale pour l'éradication de la poliomyélite : 2004-2008.\n1. Poliomyélite antérieure aiguë - prévention et contrôle  2. Vaccin antipoliomyélitique \nSabin - ressources et distribution  3. Programmes de vaccination - organisation et administration \n4. Planification stratégique  I.Titre. \nISBN 92 4 259117 3\n(Classification NLM : WC 556)\n© Organisation mondiale de la Santé 2004\nTous droits réservés. Il est possible de se procurer les publications de l’Organis",
      "truncated": true,
      "provenance": "ingested",
      "summary": {
        "status": "draft",
        "text": "The cataloguing and copyright page of the polio eradication strategic plan 2004–2008 (French edition), with ISBN, subject headings, ordering and permissions information and standard disclaimers. It also notes the typesetting and printing in Switzerland.",
        "state": "draft",
        "draftedBy": {
          "kind": "agent",
          "id": "claude-code",
          "model": "not-disclosed"
        },
        "draftedAt": "2026-11-11"
      }
    },
    {
      "id": "library/10665-42988/blocks/prose-page-003",
      "types": [
        "folio-assistant-core:Prose",
        "doco:Section"
      ],
      "kind": "prose",
      "title": "Page 3",
      "pageStart": 3,
      "pageEnd": 3,
      "target": "../sections/page-003.md",
      "narrative": null,
      "content": "Plan stratégique de l'Initiative mondiale pour\nl’éradication de la poliomyélite\n2004–2008",
      "truncated": false,
      "provenance": "ingested",
      "summary": {
        "status": "draft",
        "text": "The title page of the Global Polio Eradication Initiative Strategic Plan 2004–2008 (French edition).",
        "state": "draft",
        "draftedBy": {
          "kind": "agent",
          "id": "claude-code",
          "model": "not-disclosed"
        },
        "draftedAt": "2026-11-11"
      }
    },
    {
      "id": "library/10665-42988/blocks/prose-page-004",
      "types": [
        "folio-assistant-core:Prose",
        "doco:Section"
      ],
      "kind": "prose",
      "title": "Page 4",
      "pageStart": 4,
      "pageEnd": 4,
      "target": "../sections/page-004.md",
      "narrative": null,
      "content": "2\nPLAN STRATEGIQUE DE L’INITIATIVE MONDIALE POUR L’ERADICATION DE LA POLIOMYELITE 2004-2008\nSigles et acronymes\n3\n1 Résumé\n4\n2 Historique\n6\n3 But\n8\n4 Objectifs et étapes\n9\n4.1 Objectif Nº 1 : Interrompre la transmission du poliovirus\n9\n4.2 Objectif Nº 2 : Parvenir à la certification de l’éradication mondiale de la poliomyélite\n18\n4.3 Objectif Nº 3 : Mettre au point des produits pour la phase d’arrêt de la vaccination par\nle VPO dans le monde\n24\n4.4 Objectif Nº 4 : Intégrer l’Initiative mondiale pour l’éradication de la poliomyélite \n29\n5 Enjeux généraux\n34\n5.1 Volonté et engagement politiques",
      "truncated": true,
      "provenance": "ingested",
      "summary": {
        "status": "draft",
        "text": "The table of contents of the polio eradication strategic plan (in French), listing the summary, history, goal, four objectives, general challenges, partners' roles and the post-2008 phase of stopping oral polio vaccination.",
        "state": "draft",
        "draftedBy": {
          "kind": "agent",
          "id": "claude-code",
          "model": "not-disclosed"
        },
        "draftedAt": "2026-11-11"
      }
    },
    {
      "id": "library/10665-42988/blocks/prose-page-005",
      "types": [
        "folio-assistant-core:Prose",
        "doco:Section"
      ],
      "kind": "prose",
      "title": "Page 5",
      "pageStart": 5,
      "pageEnd": 5,
      "target": "../sections/page-005.md",
      "narrative": null,
      "content": "3\nPLAN STRATEGIQUE DE L’INITIATIVE MONDIALE POUR L’ERADICATION DE LA POLIOMYELITE 2004-2008\nS i g l e s e t a c r o n y m e s\nACDI\nAgence canadienne de Développement international\nCDC\nCenters for Disease Control and Prevention des Etats-Unis d’Amérique\nDFID\nDepartment for International Development (Royaume-Uni)\nJICA\nAgence japonaise de Coopération internationale\nJLV\nJournées locales de vaccination\nJLVi\nActivités intensifiées à l’occasion des Journées locales de vaccination\nJNV\nJournées nationales de vaccination\nJNVi\nActivités intensifiées à l’occasion des journées nationales de vaccination\nKfW",
      "truncated": true,
      "provenance": "ingested",
      "summary": {
        "status": "draft",
        "text": "A list of acronyms used in the polio eradication strategic plan (in French), such as donor agencies, national and local immunization days and vaccine types.",
        "state": "draft",
        "draftedBy": {
          "kind": "agent",
          "id": "claude-code",
          "model": "not-disclosed"
        },
        "draftedAt": "2026-11-11"
      }
    },
    {
      "id": "library/10665-42988/blocks/prose-page-006",
      "types": [
        "folio-assistant-core:Prose",
        "doco:Section"
      ],
      "kind": "prose",
      "title": "Page 6",
      "pageStart": 6,
      "pageEnd": 6,
      "target": "../sections/page-006.md",
      "narrative": null,
      "content": "4\nPLAN STRATEGIQUE DE L’INITIATIVE MONDIALE POUR L’ERADICATION DE LA POLIOMYELITE 2004-2008\nR é s u m é\n1\nÀ\nla fin de 2003, l’Initiative mondiale pour\nl’éradication de la poliomyélite, l’entreprise\nla plus importante lancée jusqu’ici dans le\ndomaine de la santé publique internationale, avait\npermis d’éliminer la maladie dans tous les pays\nsauf six1. Près de cinq millions d’enfants qui\nseraient paralysés si l’Initiative n’avait pas été\nlancée peuvent aujourd’hui marcher et la\ndistribution de vitamine A à l’occasion des\ncampagnes de vaccination antipoliomyélitique a\négalement permis d’éviter 1,2",
      "truncated": true,
      "provenance": "ingested",
      "summary": {
        "status": "draft",
        "text": "The summary of the polio eradication strategic plan (in French), stating that by end-2003 polio remained in only six countries, nearly five million children had been spared paralysis and vitamin A distribution had averted 1.25 million child deaths. It notes potential savings above US$ 1 billion a year and outlines the plan's four objectives, starting with interrupting wild poliovirus transmission. Footnotes list the remaining endemic countries and note that the plan replaces the 2001–2005 plan.",
        "state": "draft",
        "draftedBy": {
          "kind": "agent",
          "id": "claude-code",
          "model": "not-disclosed"
        },
        "draftedAt": "2026-11-11"
      }
    },
    {
      "id": "library/10665-42988/blocks/prose-page-007",
      "types": [
        "folio-assistant-core:Prose",
        "doco:Section"
      ],
      "kind": "prose",
      "title": "Page 7",
      "pageStart": 7,
      "pageEnd": 7,
      "target": "../sections/page-007.md",
      "narrative": null,
      "content": "5\nPLAN STRATEGIQUE DE L’INITIATIVE MONDIALE POUR L’ERADICATION DE LA POLIOMYELITE 2004-2008\ndanger de la vaccination par le VPO. Ces produits\nsont notamment les suivants : une troisième\nédition du Plan d’action mondial de l’OMS pour le\nconfinement des poliovirus sauvages en laboratoire\n(précisant les exigences à long terme concernant le\npoliovirus sauvage, les poliovirus dérivés d’une\nsouche vaccinale et les souches Sabin), les \nstocks de VPO monovalent (VPOm), le vaccin\nantipoliomyélitique inactivé (VPI) produit à partir\nde la souche Sabin (VPI-S) et des vaccins associés\nappropriés contenant",
      "truncated": true,
      "provenance": "ingested",
      "summary": {
        "status": "draft",
        "text": "Continues the summary (in French), describing the products needed to stop oral polio vaccine (OPV) use, such as laboratory containment guidance, monovalent OPV stockpiles and Sabin-strain inactivated vaccine. It describes the fourth objective, integrating polio eradication resources into other disease control programmes, and refers to the separate estimate of financial needs.",
        "state": "draft",
        "draftedBy": {
          "kind": "agent",
          "id": "claude-code",
          "model": "not-disclosed"
        },
        "draftedAt": "2026-11-11"
      }
    },
    {
      "id": "library/10665-42988/blocks/figure-vfig-p008",
      "types": [
        "folio-assistant-core:Figure",
        "doco:Figure"
      ],
      "kind": "figure",
      "title": "",
      "pageStart": 8,
      "pageEnd": 8,
      "target": "../figures/vfig-p008.webp",
      "narrative": "draft",
      "content": "Figure 1 is a timeline with year headings 2004, 2005, 2006, 2007, 2008 and “2009 et au-delà”, and seven horizontal bars starting in 2004 for the main targets: interrompre la transmission du poliovirus; parvenir à la certification – surveillance type dans tous les pays; mener à bien la vaccination supplémentaire; achever la phase II du confinement en laboratoire; certifier l’éradication mondiale; intégrer les activités à long terme et les ressources humaines de l’éradication de la poliomyélite; and passage à une politique à long terme de vaccination antipoliomyélitique. The bars get progressively longer: the first ends around 2005, the laboratory containment bar around 2007, global certification around 2008, and the last two extend into 2009 and beyond.",
      "truncated": false,
      "provenance": "ingested",
      "summary": null
    },
    {
      "id": "library/10665-42988/blocks/prose-page-008",
      "types": [
        "folio-assistant-core:Prose",
        "doco:Section"
      ],
      "kind": "prose",
      "title": "Page 8",
      "pageStart": 8,
      "pageEnd": 8,
      "target": "../sections/page-008.md",
      "narrative": null,
      "content": "6\nPLAN STRATEGIQUE DE L’INITIATIVE MONDIALE POUR L’ERADICATION DE LA POLIOMYELITE 2004-2008\nH i s t o r i q u e\n2\nE\nN 1988, l’Assemblée mondiale de la Santé,\nqui réunit chaque année les ministres de la\nsanté de tous les Etats Membres de l’Organisation\nmondiale de la Santé, a décidé de lancer une action\nmondiale pour éliminer la poliomyélite. Grâce à\nl’Initiative mondiale pour l’éradication de la\npoliomyélite, la plus vaste entreprise lancée à ce\njour dans le domaine de la santé publique\ninternationale, la maladie avait disparu fin 2003\nde tous les pays sauf six, et moins de 1 000 enfants\nse so",
      "truncated": true,
      "provenance": "ingested",
      "summary": {
        "status": "draft",
        "text": "Gives the history of the polio eradication initiative (in French), launched by the World Health Assembly in 1988, and its achievements by the end of 2003. A diagram outlines the plan's timeline to 2009 and beyond, including integration of polio resources and the move to long-term polio vaccination policy.",
        "state": "draft",
        "draftedBy": {
          "kind": "agent",
          "id": "claude-code",
          "model": "not-disclosed"
        },
        "draftedAt": "2026-11-11"
      }
    },
    {
      "id": "library/10665-42988/blocks/prose-page-009",
      "types": [
        "folio-assistant-core:Prose",
        "doco:Section"
      ],
      "kind": "prose",
      "title": "Page 9",
      "pageStart": 9,
      "pageEnd": 9,
      "target": "../sections/page-009.md",
      "narrative": null,
      "content": "7\nPLAN STRATEGIQUE DE L’INITIATIVE MONDIALE POUR L’ERADICATION DE LA POLIOMYELITE 2004-2008\nd’autres faits s’accumulaient pour confirmer,\nparticulièrement dans la Région du Pacifique\noccidental, la faisabilité opérationnelle des\nstratégies appliquées initialement dans la Région\ndes Amériques. A partir de la mi-décennie 90, il\ns’est avéré possible d’amplifier rapidement les\nactivités d’éradication de sorte que, à la fin des\nannées 90, plus de 575 millions d’enfants\nrecevaient \nrégulièrement \ndu \nvaccin\nantipoliomyélitique oral (VPO) grâce aux efforts\nd’une vingtaine de millions de bénévoles dan",
      "truncated": true,
      "provenance": "ingested",
      "summary": {
        "status": "draft",
        "text": "Continues the history (in French), noting that scaled-up eradication reached over 575 million children with OPV by the late 1990s and that polio has been eliminated from 210 countries and territories. It identifies the last transmission chains in Nigeria, India and Pakistan and presents the plan as the basis for partners' annual planning.",
        "state": "draft",
        "draftedBy": {
          "kind": "agent",
          "id": "claude-code",
          "model": "not-disclosed"
        },
        "draftedAt": "2026-11-11"
      }
    },
    {
      "id": "library/10665-42988/blocks/prose-page-010",
      "types": [
        "folio-assistant-core:Prose",
        "doco:Section"
      ],
      "kind": "prose",
      "title": "Page 10",
      "pageStart": 10,
      "pageEnd": 10,
      "target": "../sections/page-010.md",
      "narrative": null,
      "content": "B u t\n3\n8\nPLAN STRATEGIQUE DE L’INITIATIVE MONDIALE POUR L’ERADICATION DE LA POLIOMYELITE 2004-2008\nL\nE\nbut de l’Initiative mondiale pour\nl’éradication de la poliomyélite est d’assurer\nl’interruption de la transmission du poliovirus\ndans le monde grâce à des mesures nationales et\ninternationales coordonnées, de tirer parti des\navantages humanitaires et économiques de\nl’éradication et d’utiliser les enseignements et\ninfrastructures issus de l’exécution pour renforcer\nles systèmes de santé et maîtriser d’autres maladies\nimportantes. ❐",
      "truncated": false,
      "provenance": "ingested",
      "summary": {
        "status": "draft",
        "text": "States the goal of the polio eradication initiative (in French): to interrupt poliovirus transmission worldwide, secure the benefits of eradication and use its lessons and infrastructure to strengthen health systems.",
        "state": "draft",
        "draftedBy": {
          "kind": "agent",
          "id": "claude-code",
          "model": "not-disclosed"
        },
        "draftedAt": "2026-11-11"
      }
    },
    {
      "id": "library/10665-42988/blocks/prose-page-011",
      "types": [
        "folio-assistant-core:Prose",
        "doco:Section"
      ],
      "kind": "prose",
      "title": "Page 11",
      "pageStart": 11,
      "pageEnd": 11,
      "target": "../sections/page-011.md",
      "narrative": null,
      "content": "9\nPLAN STRATEGIQUE DE L’INITIATIVE MONDIALE POUR L’ERADICATION DE LA POLIOMYELITE 2004-2008\nApproche stratégique :\nOn s’est efforcé d’interrompre la transmission du\npoliovirus sauvage en associant des activités de\nvaccination systématique et des activités de\nvaccination supplémentaires et en assurant une\nsurveillance de haute qualité (voir aussi la \nsection 4.2).\nLa couverture systématique élevée par trois\ndoses au moins de vaccin antipoliomyélitique oral\n(VPO3) a été au centre de l’Initiative mondiale\npour l’éradication de la poliomyélite. Cependant,\nla couverture mondiale par le VPO3 n’était",
      "truncated": true,
      "provenance": "ingested",
      "summary": {
        "status": "draft",
        "text": "Describes the strategic approach to interrupting wild poliovirus transmission (in French), combining routine and supplementary immunization with high-quality surveillance. It explains why OPV3 coverage alone did not stop polio in many developing countries, including lower seroconversion in tropical settings. It sets out supplementary immunization plans and synchronized campaigns across countries and regions.",
        "state": "draft",
        "draftedBy": {
          "kind": "agent",
          "id": "claude-code",
          "model": "not-disclosed"
        },
        "draftedAt": "2026-11-11"
      }
    },
    {
      "id": "library/10665-42988/blocks/figure-img-p012-1",
      "types": [
        "folio-assistant-core:Figure",
        "doco:Figure"
      ],
      "kind": "figure",
      "title": "",
      "pageStart": 12,
      "pageEnd": 12,
      "target": "../images/img-p012-1.webp",
      "narrative": "draft",
      "content": "Map of Africa, the Middle East and South Asia (the map in Figure 2) with endemic countries shaded pale yellow — Nigeria, Niger, Egypt, Pakistan, Afghanistan and India — and red and blue dots marking wild poliovirus cases. Dots cluster in northern Nigeria and across northern India and Pakistan, with a dense red cluster in northern India.",
      "truncated": false,
      "provenance": "ingested",
      "summary": null
    },
    {
      "id": "library/10665-42988/blocks/figure-vfig-p012",
      "types": [
        "folio-assistant-core:Figure",
        "doco:Figure"
      ],
      "kind": "figure",
      "title": "",
      "pageStart": 12,
      "pageEnd": 12,
      "target": "../figures/vfig-p012.webp",
      "narrative": "draft",
      "content": "Figure 2 is a map of wild poliovirus cases from 1 January to 9 December 2003 covering Africa, the Middle East and South Asia. Dots show wild poliovirus type 1 (red), type 3 (blue) and types 1 and 3 (black); endemic countries are shaded yellow, and green circles mark importations in West and Central Africa and the Middle East. Cases concentrate in northern Nigeria, Niger, Pakistan, Afghanistan and northern India.",
      "truncated": false,
      "provenance": "ingested",
      "summary": null
    },
    {
      "id": "library/10665-42988/blocks/prose-page-012",
      "types": [
        "folio-assistant-core:Prose",
        "doco:Section"
      ],
      "kind": "prose",
      "title": "Page 12",
      "pageStart": 12,
      "pageEnd": 12,
      "target": "../sections/page-012.md",
      "narrative": null,
      "content": "10\nPLAN STRATEGIQUE DE L’INITIATIVE MONDIALE POUR L’ERADICATION DE LA POLIOMYELITE 2004-2008\nla Santé a préconisé l’accélération des activités en\ndemandant instamment aux pays d’endémie\nd’accroître le nombre des JNV organisées chaque\nannée, de prévoir en outre des Journées locales de\nvaccination (JLV) dans les zones à risque\nparticulièrement élevé et d’introduire une\nstratégie d’administration du vaccin porte à porte\npour les JNV et les JLV6. En avril 2003, à la suite\nd’une \nnouvelle \nréduction \ndes \nzones \nde\ntransmission du poliovirus et aussi des ressources\nde plus en plus limitées dont ont",
      "truncated": true,
      "provenance": "ingested",
      "summary": {
        "status": "draft",
        "text": "Describes how the World Health Assembly and the Technical Consultative Group urged more national and local immunization days, house-to-house vaccination and a focus of resources on the last endemic areas (in French). It plans intensified mass vaccination campaigns to break remaining transmission chains. A map shows wild poliovirus cases and importations as of December 2003.",
        "state": "draft",
        "draftedBy": {
          "kind": "agent",
          "id": "claude-code",
          "model": "not-disclosed"
        },
        "draftedAt": "2026-11-11"
      }
    },
    {
      "id": "library/10665-42988/blocks/prose-page-013",
      "types": [
        "folio-assistant-core:Prose",
        "doco:Section"
      ],
      "kind": "prose",
      "title": "Page 13",
      "pageStart": 13,
      "pageEnd": 13,
      "target": "../sections/page-013.md",
      "narrative": null,
      "content": "11\nPLAN STRATEGIQUE DE L’INITIATIVE MONDIALE POUR L’ERADICATION DE LA POLIOMYELITE 2004-2008\nDans toutes les zones d’endémie, si la\ntransmission n’a pas été interrompue c’est parce\nqu’un grand nombre de jeunes enfants ont échappé\naux agents de vaccination à l’occasion des JNV\net/ou des JLV qui visaient à fournir des doses de\nVPO supplémentaires à tous les enfants. Dans la\nplupart de ces zones, notamment dans les\nprincipaux réservoirs à forte densité de population\ndu Nigéria, de l’Inde et du Pakistan, le problème\nest également aggravé par une couverture très\nfaible par la vaccination systématiq",
      "truncated": true,
      "provenance": "ingested",
      "summary": {
        "status": "draft",
        "text": "Explains that transmission persisted because many young children were missed during immunization days and routine OPV coverage was often below 25% in key reservoirs (in French). It notes repeated importations of wild poliovirus that paralysed more than 70 children between 1999 and 2003. A table lists planned national and local immunization days for 2004–2008.",
        "state": "draft",
        "draftedBy": {
          "kind": "agent",
          "id": "claude-code",
          "model": "not-disclosed"
        },
        "draftedAt": "2026-11-11"
      }
    },
    {
      "id": "library/10665-42988/blocks/prose-page-014",
      "types": [
        "folio-assistant-core:Prose",
        "doco:Section"
      ],
      "kind": "prose",
      "title": "Page 14",
      "pageStart": 14,
      "pageEnd": 14,
      "target": "../sections/page-014.md",
      "narrative": null,
      "content": "12\nPLAN STRATEGIQUE DE L’INITIATIVE MONDIALE POUR L’ERADICATION DE LA POLIOMYELITE 2004-2008\nd’endémie – Nigéria, Inde, Pakistan, Niger,\nEgypte et Afghanistan. Parmi les dernières zones\ntouchées par la transmission endémique du\npoliovirus \nsauvage \nautochtone9, \nles \ncinq\nEtats/provinces réservoirs clés de Kano (Nigéria),\nde l’Uttar Pradesh et du Bihar (Inde), ainsi que du\nSindh et de la Province de la frontière du Nord-\nOuest (Pakistan) doivent particulièrement retenir\nl’attention. Pour interrompre la transmission dans\ntoutes les zones infectées aussi rapidement que\npossible, il est prévu d’i",
      "truncated": true,
      "provenance": "ingested",
      "summary": {
        "status": "draft",
        "text": "Focuses on the key reservoir areas in Nigeria, India and Pakistan and the measures needed to reach over 90% of children in intensified campaigns, such as high-level oversight and detailed mapping (in French). It also covers mop-up responses to importations, to be integrated into WHO and UNICEF emergency arrangements by 2007.",
        "state": "draft",
        "draftedBy": {
          "kind": "agent",
          "id": "claude-code",
          "model": "not-disclosed"
        },
        "draftedAt": "2026-11-11"
      }
    },
    {
      "id": "library/10665-42988/blocks/prose-page-015",
      "types": [
        "folio-assistant-core:Prose",
        "doco:Section"
      ],
      "kind": "prose",
      "title": "Page 15",
      "pageStart": 15,
      "pageEnd": 15,
      "target": "../sections/page-015.md",
      "narrative": null,
      "content": "13\nPLAN STRATEGIQUE DE L’INITIATIVE MONDIALE POUR L’ERADICATION DE LA POLIOMYELITE 2004-2008\n3. Vaccination supplémentaire dans les zones\nexemptes de poliomyélite les plus exposées :\nLa troisième priorité de l’Initiative mondiale pour\nl’éradication de la poliomyélite consistera à éviter\nla réimplantation de la transmission du poliovirus\nsauvage dans les zones libérées de la maladie,\nsurtout à l’intérieur même des pays d’endémie.\nAinsi, en plus des JLVi, au moins deux cycles de\nJNVi continueront d’être organisées dans chacun\ndes pays d’endémie pendant deux ans à compter\ndu dernier cas enregistr",
      "truncated": true,
      "provenance": "ingested",
      "summary": {
        "status": "draft",
        "text": "Describes supplementary immunization in polio-free areas most at risk of reinfection, including campaigns for two years after the last case in endemic countries (in French). It lists high-risk polio-free countries and a table of routine OPV3 coverage against the target of 90% national coverage by 2010.",
        "state": "draft",
        "draftedBy": {
          "kind": "agent",
          "id": "claude-code",
          "model": "not-disclosed"
        },
        "draftedAt": "2026-11-11"
      }
    },
    {
      "id": "library/10665-42988/blocks/prose-page-016",
      "types": [
        "folio-assistant-core:Prose",
        "doco:Section"
      ],
      "kind": "prose",
      "title": "Page 16",
      "pageStart": 16,
      "pageEnd": 16,
      "target": "../sections/page-016.md",
      "narrative": null,
      "content": "14\nPLAN STRATEGIQUE DE L’INITIATIVE MONDIALE POUR L’ERADICATION DE LA POLIOMYELITE 2004-2008\nl’UNICEF, surtout dans le cadre de l’Alliance\nmondiale pour les vaccins et la vaccination (GAVI)\nafin \nd’améliorer \nla \ncouverture \nvaccinale\nsystématique. Dans les zones exemptes de\npoliomyélite, le renforcement de la couverture\nvaccinale systématique sera déterminant pour\nlimiter la propagation des cas importés et/ou\nl’apparition de poliovirus circulants dérivés d’une\nsouche vaccinale. Dans les zones d’endémie, les\naméliorations de la couverture systématique par le\nVPO renforceront l’effet des JNVi e",
      "truncated": true,
      "provenance": "ingested",
      "summary": {
        "status": "draft",
        "text": "Describes strengthening routine immunization with UNICEF and GAVI to limit spread of imported cases and vaccine-derived polioviruses, including a birth dose of OPV (in French). It gives a table of milestones for interrupting transmission, based on interrupting transmission by early 2005 and the Alliance's coverage target.",
        "state": "draft",
        "draftedBy": {
          "kind": "agent",
          "id": "claude-code",
          "model": "not-disclosed"
        },
        "draftedAt": "2026-11-11"
      }
    },
    {
      "id": "library/10665-42988/blocks/prose-page-017",
      "types": [
        "folio-assistant-core:Prose",
        "doco:Section"
      ],
      "kind": "prose",
      "title": "Page 17",
      "pageStart": 17,
      "pageEnd": 17,
      "target": "../sections/page-017.md",
      "narrative": null,
      "content": "15\nPLAN STRATEGIQUE DE L’INITIATIVE MONDIALE POUR L’ERADICATION DE LA POLIOMYELITE 2004-2008\nInterruption de la transmission\ndu poliovirus sauvage : les\nprincipaux enjeux\nCette section fournit des données supplémentaires\nsur les principaux enjeux que pose l’interruption\nde la transmission du poliovirus au niveau\nmondial ; les répercussions financières potentielles\nsont présentées dans l'Estimation des ressources\nfinancières extérieures nécessaires pour 2004-2008\nde l’Initiative mondiale pour l’éradication de la\npoliomyélite.\nInterruption de la transmission du poliovirus\nsauvage à fin 2004 :\nL’",
      "truncated": true,
      "provenance": "ingested",
      "summary": {
        "status": "draft",
        "text": "Sets out the main challenges to interrupting wild poliovirus transmission by end-2004 (in French), noting evidence in mid-2003 that this could be achieved within a year. It discusses the need for better campaign quality, local political engagement and resources in remaining endemic areas, with a footnote defining the immunity gap.",
        "state": "draft",
        "draftedBy": {
          "kind": "agent",
          "id": "claude-code",
          "model": "not-disclosed"
        },
        "draftedAt": "2026-11-11"
      }
    },
    {
      "id": "library/10665-42988/blocks/prose-page-018",
      "types": [
        "folio-assistant-core:Prose",
        "doco:Section"
      ],
      "kind": "prose",
      "title": "Page 18",
      "pageStart": 18,
      "pageEnd": 18,
      "target": "../sections/page-018.md",
      "narrative": null,
      "content": "16\nPLAN STRATEGIQUE DE L’INITIATIVE MONDIALE POUR L’ERADICATION DE LA POLIOMYELITE 2004-2008\nnécessaires pour vacciner chaque enfant. Il sera\nparticulièrement important d’appliquer inté-\ngralement le principe des équipes de vaccination\ncomprenant au moins une femme (l’agent de santé\nféminin local) pour avoir accès à toutes les\ncommunautés et à tous les ménages et trouver les\ntrès jeunes enfants non vaccinés les plus exposés à\nl’occasion des JLVi. Il faudra tout spécialement\naméliorer la surveillance et l’obligation de rendre\ndes comptes dans les zones tribales administrées\npar le pouvoir fédér",
      "truncated": true,
      "provenance": "ingested",
      "summary": {
        "status": "draft",
        "text": "Continues the challenges (in French), including vaccination teams with at least one woman, better accountability in Pakistan's tribal areas and the serious obstacle of intense transmission in northern Nigeria. It also covers vaccine-derived poliovirus risks and improved surveillance to understand them.",
        "state": "draft",
        "draftedBy": {
          "kind": "agent",
          "id": "claude-code",
          "model": "not-disclosed"
        },
        "draftedAt": "2026-11-11"
      }
    },
    {
      "id": "library/10665-42988/blocks/prose-page-019",
      "types": [
        "folio-assistant-core:Prose",
        "doco:Section"
      ],
      "kind": "prose",
      "title": "Page 19",
      "pageStart": 19,
      "pageEnd": 19,
      "target": "../sections/page-019.md",
      "narrative": null,
      "content": "17\nPLAN STRATEGIQUE DE L’INITIATIVE MONDIALE POUR L’ERADICATION DE LA POLIOMYELITE 2004-2008\nEn conséquence, si l’incidence d’événements\ndus à des poliovirus circulants dérivés d’une\nsouche vaccinale pourrait augmenter à la suite de\nla réduction des activités de vaccination supplé-\nmentaires au niveau mondial, ces événements\ndevraient rester rares. Néanmoins, le Groupe\nconsultatif technique (TCG) mondial réexaminera\nd’ici à 2005 ses recommandations sur l’opportuni-\nté de prévoir des activités de vaccination supplé-\nmentaires pour éviter l’émergence de poliovirus\ncirculants dérivés d’une souche",
      "truncated": true,
      "provenance": "ingested",
      "summary": {
        "status": "draft",
        "text": "Concludes that circulating vaccine-derived poliovirus events should remain rare despite fewer campaigns, with the Technical Consultative Group to review its recommendations by 2005 (in French).",
        "state": "draft",
        "draftedBy": {
          "kind": "agent",
          "id": "claude-code",
          "model": "not-disclosed"
        },
        "draftedAt": "2026-11-11"
      }
    },
    {
      "id": "library/10665-42988/blocks/prose-page-020",
      "types": [
        "folio-assistant-core:Prose",
        "doco:Section"
      ],
      "kind": "prose",
      "title": "Page 20",
      "pageStart": 20,
      "pageEnd": 20,
      "target": "../sections/page-020.md",
      "narrative": null,
      "content": "18\nPLAN STRATEGIQUE DE L’INITIATIVE MONDIALE POUR L’ERADICATION DE LA POLIOMYELITE 2004-2008\n4 . 2\nO b j e c t i f N °\n2 :\nP a r v e n i r à l a c e r t i f i c a t i o n d e\nl ’ é r a d i c a t i o n m o n d i a l e d e l a\np o l i o m y é l i t e\nL\nA démarche de certification de l’éradication mondiale de la poliomyélite a été validée par l’expérience des trois\nRégions de l’OMS certifiées exemptes de la maladie à la fin de 2003. La démarche est cependant remise en cause\npar les carences de la surveillance dans les trois dernières Régions d’endémie, par une baisse de la sensibilité de la\nsurve",
      "truncated": true,
      "provenance": "ingested",
      "summary": {
        "status": "draft",
        "text": "Describes objective 2, achieving global certification of polio eradication by 2008 (in French), noting that three WHO regions were certified by end-2003. It identifies weaknesses in surveillance and in laboratory containment of wild poliovirus as challenges. It explains the acute flaccid paralysis surveillance standards and refers to the WHO laboratory containment action plan.",
        "state": "draft",
        "draftedBy": {
          "kind": "agent",
          "id": "claude-code",
          "model": "not-disclosed"
        },
        "draftedAt": "2026-11-11"
      }
    },
    {
      "id": "library/10665-42988/blocks/prose-page-021",
      "types": [
        "folio-assistant-core:Prose",
        "doco:Section"
      ],
      "kind": "prose",
      "title": "Page 21",
      "pageStart": 21,
      "pageEnd": 21,
      "target": "../sections/page-021.md",
      "narrative": null,
      "content": "19\nPLAN STRATEGIQUE DE L’INITIATIVE MONDIALE POUR L’ERADICATION DE LA POLIOMYELITE 2004-2008\nparticulières définissant les règles de sécurité bio-\nlogique à appliquer après l’interruption de la\ntransmission du poliovirus sauvage ont été élabo-\nrées et mises au point définitivement en 2003, en\ncollaboration avec les autorités nationales de \nréglementation et des spécialistes de la sécurité\nbiologique. La certification mondiale sera condi-\ntionnée par l’application de ces règles dans tous les\npays où l’on continue à fabriquer du VPI.\nAnalyse de la situation :\nComme l’avait demandé la Commission",
      "truncated": true,
      "provenance": "ingested",
      "summary": {
        "status": "draft",
        "text": "Describes biosafety rules for inactivated polio vaccine production after transmission ends and the structure of global, regional and national certification commissions (in French). It analyses the status of certification by region and includes a figure on population in regions by certification status.",
        "state": "draft",
        "draftedBy": {
          "kind": "agent",
          "id": "claude-code",
          "model": "not-disclosed"
        },
        "draftedAt": "2026-11-11"
      }
    },
    {
      "id": "library/10665-42988/blocks/prose-page-022",
      "types": [
        "folio-assistant-core:Prose",
        "doco:Section"
      ],
      "kind": "prose",
      "title": "Page 22",
      "pageStart": 22,
      "pageEnd": 22,
      "target": "../sections/page-022.md",
      "narrative": null,
      "content": "20\nPLAN STRATEGIQUE DE L’INITIATIVE MONDIALE POUR L’ERADICATION DE LA POLIOMYELITE 2004-2008\nspécialisés (7). La qualité du travail des\nlaboratoires est garantie par des contrôles annuels,\npar un programme officiel d’accréditation et par\nune évaluation continue à l’aide d’indicateurs\ntypes. En 2002, 99 % des laboratoires du réseau\nétaient agréés par l’OMS ; 100 % des échantillons\nétaient contrôlés dans un laboratoire agréé par\nl’OMS qui recevait des échantillons en provenance\nde pays dont les laboratoires n’étaient pas agréés.\nA la mi-1999, l’Assemblée mondiale de la\nSanté a instamment prié to",
      "truncated": true,
      "provenance": "ingested",
      "summary": {
        "status": "draft",
        "text": "Describes the global polio laboratory network and its quality assurance, with 99% of laboratories WHO-accredited in 2002 (in French). It reports progress in laboratory containment, with 148 countries having started or completed inventories by mid-2003, and plans to maintain network resources, citing resolution WHA52.22.",
        "state": "draft",
        "draftedBy": {
          "kind": "agent",
          "id": "claude-code",
          "model": "not-disclosed"
        },
        "draftedAt": "2026-11-11"
      }
    },
    {
      "id": "library/10665-42988/blocks/figure-img-p023-1",
      "types": [
        "folio-assistant-core:Figure",
        "doco:Figure"
      ],
      "kind": "figure",
      "title": "",
      "pageStart": 23,
      "pageEnd": 23,
      "target": "../images/img-p023-1.webp",
      "narrative": "draft",
      "content": "World map (top panel of Figure 3) colouring countries by an AFP surveillance rate indicator: most of Africa, Asia, the Russian Federation and Latin America are dark green (≥1), while Brazil and several European and Asian countries are yellow (0.5–1) and Australia, Algeria and some European countries are red (<0.5). North America, much of western Europe and Japan are light grey, indicating no AFP surveillance.",
      "truncated": false,
      "provenance": "ingested",
      "summary": null
    },
    {
      "id": "library/10665-42988/blocks/figure-img-p023-2",
      "types": [
        "folio-assistant-core:Figure",
        "doco:Figure"
      ],
      "kind": "figure",
      "title": "",
      "pageStart": 23,
      "pageEnd": 23,
      "target": "../images/img-p023-2.webp",
      "narrative": "draft",
      "content": "World map (bottom panel of Figure 3) colouring countries by the rate of adequate stool specimen collection: most of Africa, Asia and the Russian Federation are dark green (≥80%), Brazil, Argentina, Mongolia and several African and European countries are yellow (60%–80%), and Australia, Spain and some other European and South American countries are red (<60%). North America, much of western Europe and Japan are light grey (no AFP surveillance).",
      "truncated": false,
      "provenance": "ingested",
      "summary": null
    },
    {
      "id": "library/10665-42988/blocks/figure-vfig-p023",
      "types": [
        "folio-assistant-core:Figure",
        "doco:Figure"
      ],
      "kind": "figure",
      "title": "",
      "pageStart": 23,
      "pageEnd": 23,
      "target": "../figures/vfig-p023.webp",
      "narrative": "draft",
      "content": "Figure 3 shows two world maps of AFP surveillance performance indicators, 1 January–25 November 2003: the top map is coloured by rate (<0.5 red, 0.5–1 yellow, ≥1 green) and the bottom map by adequate stool collection rate (<60% red, 60%–80% yellow, ≥80% green), with grey for no AFP surveillance; most of Africa and Asia are green, and North America and much of western Europe are grey. Figure 4 is a world map of the Global Polio Laboratory Network, 2002, marking specialized reference laboratories (blue stars, e.g. in the United States, Europe, India and Japan), regional reference laboratories (green circles) and national/subnational laboratories (red triangles), the latter densest in Europe, South and East Asia and Africa.",
      "truncated": false,
      "provenance": "ingested",
      "summary": null
    },
    {
      "id": "library/10665-42988/blocks/prose-page-023",
      "types": [
        "folio-assistant-core:Prose",
        "doco:Section"
      ],
      "kind": "prose",
      "title": "Page 23",
      "pageStart": 23,
      "pageEnd": 23,
      "target": "../sections/page-023.md",
      "narrative": null,
      "content": "21\nPLAN STRATEGIQUE DE L’INITIATIVE MONDIALE POUR L’ERADICATION DE LA POLIOMYELITE 2004-2008\n< 0.5\n 0.5 -1\n > 1\nNo AFP Surveillance\nNon-polio AFP rate\nAdequate stool collection rate\n< 60%\n 60% -80%\n > 80%\nNo AFP Surveillance\nData in WHO HQ as of 25 November 2003.\nThe boundaries and names shown and the designations used on this map do not imply the\nexpression of any opinion whatsoever on the part of the World Health Organization concerning\nthe legal status of any country, territory, city or area or of its authorities, or concerning the\ndelimitation of its frontiers or boundaries.  Dotted lines",
      "truncated": true,
      "provenance": "ingested",
      "summary": {
        "status": "draft",
        "text": "Maps of acute flaccid paralysis surveillance performance indicators for 2003, showing non-polio AFP rates and adequate stool collection rates by country, with map disclaimers in English and French.",
        "state": "draft",
        "draftedBy": {
          "kind": "agent",
          "id": "claude-code",
          "model": "not-disclosed"
        },
        "draftedAt": "2026-11-11"
      }
    },
    {
      "id": "library/10665-42988/blocks/prose-page-024",
      "types": [
        "folio-assistant-core:Prose",
        "doco:Section"
      ],
      "kind": "prose",
      "title": "Page 24",
      "pageStart": 24,
      "pageEnd": 24,
      "target": "../sections/page-024.md",
      "narrative": null,
      "content": "22\nPLAN STRATEGIQUE DE L’INITIATIVE MONDIALE POUR L’ERADICATION DE LA POLIOMYELITE 2004-2008\nréseau mondial mais sont chargés de fonctions\nbeaucoup plus larges continuent d'affecter les\nressources humaines, les installations et le\nmatériel \nsuffisant \nà \nl’éradication \nde \nla\npoliomyélite. Pendant cette même période, on\nprévoit que l’activité du réseau de laboratoires va\nen fait augmenter, puisqu’il faudra répondre aux\ndemandes de données virologiques supplé-\nmentaires en prévision de la certification\nmondiale. Ces impératifs en matière de données\n(par exemple surveillance environnementale\ncib",
      "truncated": true,
      "provenance": "ingested",
      "summary": {
        "status": "draft",
        "text": "Describes future laboratory network activity and data needs ahead of global certification, and priorities for containing wild and vaccine-derived polioviruses under the 2003 global action plan (in French). It also covers WHO support to certification commissions.",
        "state": "draft",
        "draftedBy": {
          "kind": "agent",
          "id": "claude-code",
          "model": "not-disclosed"
        },
        "draftedAt": "2026-11-11"
      }
    },
    {
      "id": "library/10665-42988/blocks/prose-page-025",
      "types": [
        "folio-assistant-core:Prose",
        "doco:Section"
      ],
      "kind": "prose",
      "title": "Page 25",
      "pageStart": 25,
      "pageEnd": 25,
      "target": "../sections/page-025.md",
      "narrative": null,
      "content": "23\nPLAN STRATEGIQUE DE L’INITIATIVE MONDIALE POUR L’ERADICATION DE LA POLIOMYELITE 2004-2008\n85 %\n100 %\n50 %\n(phase I)\nND*\n60 %\n(certification\nrégionale)\n2 0 0 4\n90 %\n100 %\n75 %\n(phase I)\nND*\n70 %\n(certification\nrégionale)\n2 0 0 5\n100 %\n100 %\n100 %\n(phase I)\nND*\n85 %\n(certification\nrégionale)\n2 0 0 6\n100 %\n100 %\n100 %\n(phase II)\n60 %\n100 %\n(certification\nrégionale)\n2 0 0 7\n100 %\n100 %\n100 %\n(phase II +)\n100 %\n100 %\n(certification\nmondiale)\n2 0 0 8\nI n d i c a t e u r s\nPourcentage de pays non\ncertifiés où la surveillance est\nconforme aux normes de la\ncertification\nPourcentage d’échantillons\npr",
      "truncated": true,
      "provenance": "ingested",
      "summary": {
        "status": "draft",
        "text": "A table of indicators and annual milestones for objective 2 (in French), covering certification-standard surveillance, testing in accredited laboratories, containment phases, biosafety for inactivated vaccine production and submission of final certification documents from 2004 to 2008.",
        "state": "draft",
        "draftedBy": {
          "kind": "agent",
          "id": "claude-code",
          "model": "not-disclosed"
        },
        "draftedAt": "2026-11-11"
      }
    },
    {
      "id": "library/10665-42988/blocks/prose-page-026",
      "types": [
        "folio-assistant-core:Prose",
        "doco:Section"
      ],
      "kind": "prose",
      "title": "Page 26",
      "pageStart": 26,
      "pageEnd": 26,
      "target": "../sections/page-026.md",
      "narrative": null,
      "content": "24\nPLAN STRATEGIQUE DE L’INITIATIVE MONDIALE POUR L’ERADICATION DE LA POLIOMYELITE 2004-2008\n4 . 3\nO b j e c t i f N °\n3 :\nM e t t r e a u p o i n t d e s p r o d u i t s p o u r\nl a p h a s e d ’ a r r ê t d e l a v a c c i n a t i o n\np a r l e V P O d a n s l e m o n d e\nD\nEPUIS 2000, les flambées de poliomyélite provoquées par des poliovirus dérivés d’une souche vaccinale (PDSV) ont\nmontré de façon concluante que la poursuite de l’utilisation du VPO pour la vaccination systématique risquait de\nremettre en cause l’élimination de tous les cas de maladie paralytique dus à des poliovirus circu",
      "truncated": true,
      "provenance": "ingested",
      "summary": {
        "status": "draft",
        "text": "Describes objective 3, developing products for stopping OPV use globally (in French), explaining that outbreaks of vaccine-derived poliovirus since 2000 show that continued OPV use could threaten eradication. It states that routine OPV use should stop as soon as possible after certification while surveillance and immunity are high. It introduces the policy areas the Technical Consultative Group said must be addressed.",
        "state": "draft",
        "draftedBy": {
          "kind": "agent",
          "id": "claude-code",
          "model": "not-disclosed"
        },
        "draftedAt": "2026-11-11"
      }
    },
    {
      "id": "library/10665-42988/blocks/prose-page-027",
      "types": [
        "folio-assistant-core:Prose",
        "doco:Section"
      ],
      "kind": "prose",
      "title": "Page 27",
      "pageStart": 27,
      "pageEnd": 27,
      "target": "../sections/page-027.md",
      "narrative": null,
      "content": "25\nPLAN STRATEGIQUE DE L’INITIATIVE MONDIALE POUR L’ERADICATION DE LA POLIOMYELITE 2004-2008\nformuler de nouvelles politiques dans quatre\ndomaines interdépendants : 1) la vaccination\nsystématique ; 2) la détection et la notification\ndes poliovirus circulants, qui sont des questions\nd’urgence pour la santé publique ; 3) les stocks de\nvaccin antipoliomyélitique et les mécanismes de\nriposte aux flambées ; 4) le confinement\nbiologique à long terme de toutes les souches de\npoliovirus.\nAnalyse de la situation :\nEn 1998, une consultation d’experts convoquée\npar l’OMS pour analyser la base scientifiqu",
      "truncated": true,
      "provenance": "ingested",
      "summary": {
        "status": "draft",
        "text": "Lists four policy areas for stopping OPV (routine immunization, detection and notification of circulating poliovirus, vaccine stockpiles and outbreak response, and long-term containment) and summarises the 1998 expert consultation on stopping polio vaccination (in French). A table estimates risks of paralytic polio after global certification.",
        "state": "draft",
        "draftedBy": {
          "kind": "agent",
          "id": "claude-code",
          "model": "not-disclosed"
        },
        "draftedAt": "2026-11-11"
      }
    },
    {
      "id": "library/10665-42988/blocks/prose-page-028",
      "types": [
        "folio-assistant-core:Prose",
        "doco:Section"
      ],
      "kind": "prose",
      "title": "Page 28",
      "pageStart": 28,
      "pageEnd": 28,
      "target": "../sections/page-028.md",
      "narrative": null,
      "content": "26\nPLAN STRATEGIQUE DE L’INITIATIVE MONDIALE POUR L’ERADICATION DE LA POLIOMYELITE 2004-2008\nParmi les principaux faits nouveaux dans le\ndomaine des consultations publiques, il convient\nde mentionner une réunion organisée en 2002 au\ncours de laquelle de nombreux décideurs venus de\ndivers horizons ont réaffirmé l’espoir exprimé au\nniveau international, et en particulier par les pays\nà faible revenu et à revenu intermédiaire, que la\nvaccination systématique contre la poliomyélite\ncesserait un jour. Tout aussi importante a été la\nconsultation \ninternationale \norganisée \nen\nseptembre 2003 sur les",
      "truncated": true,
      "provenance": "ingested",
      "summary": {
        "status": "draft",
        "text": "Describes public consultations, including a 2002 meeting and a 2003 consultation that concluded vaccine-derived polioviruses pose a real risk for as long as OPV is used (in French). It explains why OPV should be stopped soon after certification, as surveillance and coverage tend to decline once regions are certified.",
        "state": "draft",
        "draftedBy": {
          "kind": "agent",
          "id": "claude-code",
          "model": "not-disclosed"
        },
        "draftedAt": "2026-11-11"
      }
    },
    {
      "id": "library/10665-42988/blocks/prose-page-029",
      "types": [
        "folio-assistant-core:Prose",
        "doco:Section"
      ],
      "kind": "prose",
      "title": "Page 29",
      "pageStart": 29,
      "pageEnd": 29,
      "target": "../sections/page-029.md",
      "narrative": null,
      "content": "27\nPLAN STRATEGIQUE DE L’INITIATIVE MONDIALE POUR L’ERADICATION DE LA POLIOMYELITE 2004-2008\nproduction de VPI à partir de poliovirus sauvages,\non encouragera la mise au point de VPI fabriqué\nà partir de souches atténuées (c’est-à-dire souches\nSabin) de poliovirus.\n2. Détection et notification des poliovirus\ncirculants : Avec l’élimination de la transmission\ndu poliovirus sauvage dans le monde, la détection\nde tout poliovirus circulant devra être considérée\ncomme une question d’urgence pour la santé\npublique internationale, car il faudra réagir\nrapidement. C’est pourquoi la notification et\nl’i",
      "truncated": true,
      "provenance": "ingested",
      "summary": {
        "status": "draft",
        "text": "Describes encouraging Sabin-strain inactivated polio vaccine and treating any circulating poliovirus detected after eradication as a public health emergency requiring immediate notification (in French). It also covers aligning AFP reporting with other WHO alert systems and developing a containment plan for the OPV cessation phase.",
        "state": "draft",
        "draftedBy": {
          "kind": "agent",
          "id": "claude-code",
          "model": "not-disclosed"
        },
        "draftedAt": "2026-11-11"
      }
    },
    {
      "id": "library/10665-42988/blocks/prose-page-030",
      "types": [
        "folio-assistant-core:Prose",
        "doco:Section"
      ],
      "kind": "prose",
      "title": "Page 30",
      "pageStart": 30,
      "pageEnd": 30,
      "target": "../sections/page-030.md",
      "narrative": null,
      "content": "28\nPLAN STRATEGIQUE DE L’INITIATIVE MONDIALE POUR L’ERADICATION DE LA POLIOMYELITE 2004-2008\nde PDSV en laboratoire soient adaptées aux\nrisques. Le Plan servira par ailleurs à définir les\nnormes supplémentaires à adopter dans la\nperspective de l’arrêt de l’utilisation du VPO pour\nprotéger le personnel des établissements de\nproduction du VPI contre une infection\nsubclinique. Contrairement à la deuxième édition\ndu Plan d’action, la troisième servira également à\nréunir un consensus sur les niveaux appropriés de\nsécurité biologique pour la manipulation des\nsouches Sabin et les souches dérivées de",
      "truncated": true,
      "provenance": "ingested",
      "summary": {
        "status": "draft",
        "text": "Continues Objective 3 of the French edition of the Global Polio Eradication Initiative Strategic Plan 2004–2008, on preparing products for stopping oral polio vaccine (OPV), describing how a third edition of the laboratory containment action plan will set biosafety standards for Sabin strains and vaccine production sites. It notes that long-term containment monitoring will be harmonized with arrangements for other high-risk pathogens. A table sets yearly milestones from 2004 to 2008 and indicators, such as monovalent OPV stockpiles, licensing Sabin-based inactivated vaccine, integration with the International Health Regulations and OPV cessation.",
        "state": "draft",
        "draftedBy": {
          "kind": "agent",
          "id": "claude-code",
          "model": "not-disclosed"
        },
        "draftedAt": "2026-11-11"
      }
    },
    {
      "id": "library/10665-42988/blocks/prose-page-031",
      "types": [
        "folio-assistant-core:Prose",
        "doco:Section"
      ],
      "kind": "prose",
      "title": "Page 31",
      "pageStart": 31,
      "pageEnd": 31,
      "target": "../sections/page-031.md",
      "narrative": null,
      "content": "29\nPLAN STRATEGIQUE DE L’INITIATIVE MONDIALE POUR L’ERADICATION DE LA POLIOMYELITE 2004-2008\n4 . 4\nO b j e c t i f N °\n4 :\nI n t é g r e r l ’ I n i t i a t i v e m o n d i a l e\np o u r l ’ é r a d i c a t i o n d e l a\np o l i o m y é l i t e \nL\n’ Initiative mondiale pour l’éradication de la poliomyélite a aidé à assurer d’autres services de santé, en particulier\ndepuis le milieu des années 90, moyennant des activités telles que la distribution de suppléments de vitamine A, la\nsurveillance intégrée des maladies, l’amélioration des services de vaccination systématique et, plus récemment, la m",
      "truncated": true,
      "provenance": "ingested",
      "summary": {
        "status": "draft",
        "text": "Introduces Objective 4, integrating the polio eradication initiative into broader health services, noting its support since the mid-1990s for vitamin A distribution, integrated disease surveillance, routine immunization and GAVI activities. It explains how supplementary immunization campaigns were used to add other interventions, upgrade routine services such as the cold chain and training, and build community demand. It adds that coordination bodies such as interagency committees and technical advisory groups have taken on strengthening routine immunization.",
        "state": "draft",
        "draftedBy": {
          "kind": "agent",
          "id": "claude-code",
          "model": "not-disclosed"
        },
        "draftedAt": "2026-11-11"
      }
    },
    {
      "id": "library/10665-42988/blocks/prose-page-032",
      "types": [
        "folio-assistant-core:Prose",
        "doco:Section"
      ],
      "kind": "prose",
      "title": "Page 32",
      "pageStart": 32,
      "pageEnd": 32,
      "target": "../sections/page-032.md",
      "narrative": null,
      "content": "30\nPLAN STRATEGIQUE DE L’INITIATIVE MONDIALE POUR L’ERADICATION DE LA POLIOMYELITE 2004-2008\nPour mener à bien les activités d’éradication,\nle Partenariat contre la poliomyélite a beaucoup\ninvesti dans les ressources humaines, les\ninfrastructures matérielles et les arrangements\ninstitutionnels. Il sera déterminant d’intégrer cet\ninvestissement dans les systèmes nationaux de\nvaccination et de surveillance pour que\nl’expérience, les enseignements et les moyens de\nl’éradication de la poliomyélite gardent leur\nutilité, notamment pour le suivi de la session\nextraordinaire de l’Assemblée générale de",
      "truncated": true,
      "provenance": "ingested",
      "summary": {
        "status": "draft",
        "text": "Explains that the polio partnership has invested heavily in staff, infrastructure and institutional arrangements, which should be integrated into national immunization and surveillance systems to support goals such as higher routine coverage and lower measles mortality. Its situation analysis notes that polio technical advisory groups now serve wider immunization work, that national interagency coordinating committees became the channel for GAVI support and a model for the Global Fund, and that polio-funded staff already spend much of their time on other priorities. Footnotes cite the advisory groups and a 2001 WHO survey of polio-funded staff.",
        "state": "draft",
        "draftedBy": {
          "kind": "agent",
          "id": "claude-code",
          "model": "not-disclosed"
        },
        "draftedAt": "2026-11-11"
      }
    },
    {
      "id": "library/10665-42988/blocks/prose-page-033",
      "types": [
        "folio-assistant-core:Prose",
        "doco:Section"
      ],
      "kind": "prose",
      "title": "Page 33",
      "pageStart": 33,
      "pageEnd": 33,
      "target": "../sections/page-033.md",
      "narrative": null,
      "content": "31\nPLAN STRATEGIQUE DE L’INITIATIVE MONDIALE POUR L’ERADICATION DE LA POLIOMYELITE 2004-2008\ny réagir. Dans la Région africaine de l’OMS, le\nréseau PFA a servi de cadre pour la « surveillance\nintégrée des maladies ». En 1998, 86 % des pays\nde cette Région y avaient inclus la rougeole et le\ntétanos néonatal et 60 % avaient inclus le choléra\net la méningite. Aux Amériques, la surveillance\nde la poliomyélite et de la rougeole est\nétroitement intégrée depuis 1994. En 2001,\nl’OMS et l’UNICEF ont commencé à former\nsystématiquement les personnels financés par la\nlutte contre la poliomyélite dans les",
      "truncated": true,
      "provenance": "ingested",
      "summary": {
        "status": "draft",
        "text": "Gives examples of integration, such as the acute flaccid paralysis network serving as a base for integrated disease surveillance in the WHO African Region and joint polio and measles surveillance in the Americas, and WHO and UNICEF training of polio-funded staff to support routine immunization. It sets out planned work, beginning with transferring polio-funded human resources and engaging stakeholders. It then describes extending acute flaccid paralysis surveillance to other diseases of public health importance.",
        "state": "draft",
        "draftedBy": {
          "kind": "agent",
          "id": "claude-code",
          "model": "not-disclosed"
        },
        "draftedAt": "2026-11-11"
      }
    },
    {
      "id": "library/10665-42988/blocks/prose-page-034",
      "types": [
        "folio-assistant-core:Prose",
        "doco:Section"
      ],
      "kind": "prose",
      "title": "Page 34",
      "pageStart": 34,
      "pageEnd": 34,
      "target": "../sections/page-034.md",
      "narrative": null,
      "content": "32\nPLAN STRATEGIQUE DE L’INITIATIVE MONDIALE POUR L’ERADICATION DE LA POLIOMYELITE 2004-2008\ndes maladies dans les pays où existent structures\net moyens, la priorité Nº 1 étant les pays où les\nsystèmes sont les plus développés et qui ont été\ncertifiés exempts de poliomyélite. Dans les pays\noù ces moyens n’existent pas, le système de\nsurveillance de la PFA sera développé de manière\nà faciliter détection, investigation et riposte pour\nles maladies évitables par la vaccination et\nd’autres maladies revêtant de l’importance pour la\nsanté publique (particulièrement les maladies\nayant un potentiel ép",
      "truncated": true,
      "provenance": "ingested",
      "summary": {
        "status": "draft",
        "text": "Describes two approaches to integrating surveillance: merging acute flaccid paralysis surveillance into routine systems where capacity exists, prioritizing certified polio-free countries, or building it up to cover other vaccine-preventable and epidemic-prone diseases elsewhere. It notes that countries needing long-term surveillance support will be identified by the end of 2004. It also discusses applying polio eradication lessons to other health goals, especially the Millennium Development Goal target on child mortality.",
        "state": "draft",
        "draftedBy": {
          "kind": "agent",
          "id": "claude-code",
          "model": "not-disclosed"
        },
        "draftedAt": "2026-11-11"
      }
    },
    {
      "id": "library/10665-42988/blocks/prose-page-035",
      "types": [
        "folio-assistant-core:Prose",
        "doco:Section"
      ],
      "kind": "prose",
      "title": "Page 35",
      "pageStart": 35,
      "pageEnd": 35,
      "target": "../sections/page-035.md",
      "narrative": null,
      "content": "33\nPLAN STRATEGIQUE DE L’INITIATIVE MONDIALE POUR L’ERADICATION DE LA POLIOMYELITE 2004-2008\nles domaines des ressources humaines, du\nfinancement ainsi que de l’administration et de la\ngestion soit mise à profit pour les activités\ninternationales visant à réduire durablement la\nmortalité et la morbidité rougeoleuses ainsi qu’à\ndévelopper la couverture d’interventions de santé\ntelles que la distribution de vitamine A, la\ndistribution de moustiquaires imprégnées\nd’insecticide \nou \nle \ntraitement \npar \nles\nantirétroviraux. ❐\n25 %\n50 %\n25 %\n25 %\n50 %\n2 0 0 4\n50 %\n75 %\n50 %\n50 %\n75 %\n2 0 0 5\n75 %\n1",
      "truncated": true,
      "provenance": "ingested",
      "summary": {
        "status": "draft",
        "text": "Adds that polio experience in human resources, financing and management should support efforts against measles and the expansion of interventions such as vitamin A, insecticide-treated nets and antiretroviral treatment. A table sets yearly percentage targets from 2004 to 2008 for Objective 4 indicators, such as priority countries implementing integrated plans and full integration of polio operations into measles activities.",
        "state": "draft",
        "draftedBy": {
          "kind": "agent",
          "id": "claude-code",
          "model": "not-disclosed"
        },
        "draftedAt": "2026-11-11"
      }
    },
    {
      "id": "library/10665-42988/blocks/prose-page-036",
      "types": [
        "folio-assistant-core:Prose",
        "doco:Section"
      ],
      "kind": "prose",
      "title": "Page 36",
      "pageStart": 36,
      "pageEnd": 36,
      "target": "../sections/page-036.md",
      "narrative": null,
      "content": "34\nPLAN STRATEGIQUE DE L’INITIATIVE MONDIALE POUR L’ERADICATION DE LA POLIOMYELITE 2004-2008\nE n j e u x g é n é r a u x\n5\nO\nUTRE les deux enjeux spécifiques déjà\nmentionnés \nauxquels \nse \nheurte\nl’interruption de la transmission du poliovirus, il\nse pose six grands enjeux qui ont tous à voir avec\nles quatre objectifs exposés ici. On trouvera dans\nles paragraphes qui suivent un aperçu de chacun\nde ces enjeux et des activités prévues par le\nPartenariat pour l’éradication de la poliomyélite\nafin d’en atténuer les éventuels effets négatifs.\n5 . 1\nV o l o n t é e t e n g a g e m e n t\np o l i t i",
      "truncated": true,
      "provenance": "ingested",
      "summary": {
        "status": "draft",
        "text": "Opens the chapter on general challenges facing polio eradication, starting with the need for sustained high-level political commitment in endemic and donor countries, supported by country-by-country advocacy. It then covers external financing, noting the US$ 150 million needed to interrupt transmission and US$ 380 million for certification and integration in 2004–2005. It recalls the 2003 funding shortfalls that forced activities to be cancelled and describes resource mobilization efforts targeting G8 countries.",
        "state": "draft",
        "draftedBy": {
          "kind": "agent",
          "id": "claude-code",
          "model": "not-disclosed"
        },
        "draftedAt": "2026-11-11"
      }
    },
    {
      "id": "library/10665-42988/blocks/prose-page-037",
      "types": [
        "folio-assistant-core:Prose",
        "doco:Section"
      ],
      "kind": "prose",
      "title": "Page 37",
      "pageStart": 37,
      "pageEnd": 37,
      "target": "../sections/page-037.md",
      "narrative": null,
      "content": "35\nPLAN STRATEGIQUE DE L’INITIATIVE MONDIALE POUR L’ERADICATION DE LA POLIOMYELITE 2004-2008\n5 . 3\nV a c c i n s\na n t i p o l i o m y é l i t i q u e s d e\nq u a l i t é\nPour atteindre tous les grands objectifs énoncés\ndans \nce \nplan, \nil \nfaudra \ngarantir \nun\napprovisionnement \nfiable \nen \nvaccins\nantipoliomyélitiques de qualité. Pour briser les\ndernières chaînes de transmission du poliovirus, il\nfaudra environ 2,5 milliards de doses de VPO\npréqualifié par l’OMS pour les activités de\nvaccination supplémentaires pendant la période\n2004-2005. Il faudra de plus du VPO pour les\nactivités de vacc",
      "truncated": true,
      "provenance": "ingested",
      "summary": {
        "status": "draft",
        "text": "Discusses the need for a reliable supply of quality polio vaccines, including about 2.5 billion doses of WHO-prequalified OPV for supplementary campaigns in 2004–2005, continued OPV production capacity for stockpiles and growing demand for inactivated vaccine. It then covers conflict-affected countries and areas, where special arrangements will be needed for immunization, certification and staff security. It also introduces communication, advocacy and social mobilization needs in endemic areas and donor countries.",
        "state": "draft",
        "draftedBy": {
          "kind": "agent",
          "id": "claude-code",
          "model": "not-disclosed"
        },
        "draftedAt": "2026-11-11"
      }
    },
    {
      "id": "library/10665-42988/blocks/prose-page-038",
      "types": [
        "folio-assistant-core:Prose",
        "doco:Section"
      ],
      "kind": "prose",
      "title": "Page 38",
      "pageStart": 38,
      "pageEnd": 38,
      "target": "../sections/page-038.md",
      "narrative": null,
      "content": "36\nPLAN STRATEGIQUE DE L’INITIATIVE MONDIALE POUR L’ERADICATION DE LA POLIOMYELITE 2004-2008\nd’ici à la certification mondiale. Dans tous les\npays, l’élaboration de politiques à long terme pour\nla poliomyélite, notamment en ce qui concerne la\nvaccination systématique, créera de nouvelles\ndemandes dans ce domaine d’activité.\nIl faut intensifier les efforts de mobilisation\nsociale dans les dernières zones d’endémie pour\nassocier pleinement les populations touchées par la\npoliomyélite et dissiper les rumeurs qui ont\nparfois sapé la confiance dans le programme. La\nsélection et la formation des age",
      "truncated": true,
      "provenance": "ingested",
      "summary": {
        "status": "draft",
        "text": "Calls for stronger social mobilization in the last endemic areas to engage communities and counter rumours that have undermined trust, with attention to vaccinator training, inclusion of women and suitable communication materials. It then covers biocontainment, setting deadlines for countries to inventory laboratories holding wild poliovirus by the end of 2004 and to destroy materials or move to higher containment levels later. It notes the particular challenge of containment in facilities producing inactivated vaccine from wild poliovirus.",
        "state": "draft",
        "draftedBy": {
          "kind": "agent",
          "id": "claude-code",
          "model": "not-disclosed"
        },
        "draftedAt": "2026-11-11"
      }
    },
    {
      "id": "library/10665-42988/blocks/prose-page-039",
      "types": [
        "folio-assistant-core:Prose",
        "doco:Section"
      ],
      "kind": "prose",
      "title": "Page 39",
      "pageStart": 39,
      "pageEnd": 39,
      "target": "../sections/page-039.md",
      "narrative": null,
      "content": "37\nPLAN STRATEGIQUE DE L’INITIATIVE MONDIALE POUR L’ERADICATION DE LA POLIOMYELITE 2004-2008\nL e r ô l e d e s\np a r t e n a i r e s\n6\n6 . 1\nG o u v e r n e m e n t s\nLes gouvernements des pays où la poliomyélite est\nendémique ou l’était récemment ainsi que les pays\nexempts de la maladie sont les maîtres en même\ntemps que les bénéficiaires de l’Initiative mondiale\npour l’éradication de la poliomyélite, au titre de\nlaquelle ils mènent toute la gamme des activités\nd’éradication décrites ici. Des ressources sont\nengagées par les pays pour la mise en œuvre des\nactivités d’éradication tant en espèc",
      "truncated": true,
      "provenance": "ingested",
      "summary": {
        "status": "draft",
        "text": "Opens the chapter on the role of partners, describing governments of endemic, recently endemic and polio-free countries as owners and beneficiaries of the initiative who contribute cash and in-kind resources. It then outlines the roles of the spearheading partners, WHO, providing technical leadership, coordination and surveillance support, and Rotary International, which has committed over US$ 500 million and mobilized volunteers through its PolioPlus programme. It begins describing the contributions of UNICEF and the US Centers for Disease Control and Prevention.",
        "state": "draft",
        "draftedBy": {
          "kind": "agent",
          "id": "claude-code",
          "model": "not-disclosed"
        },
        "draftedAt": "2026-11-11"
      }
    },
    {
      "id": "library/10665-42988/blocks/prose-page-040",
      "types": [
        "folio-assistant-core:Prose",
        "doco:Section"
      ],
      "kind": "prose",
      "title": "Page 40",
      "pageStart": 40,
      "pageEnd": 40,
      "target": "../sections/page-040.md",
      "narrative": null,
      "content": "38\nPLAN STRATEGIQUE DE L’INITIATIVE MONDIALE POUR L’ERADICATION DE LA POLIOMYELITE 2004-2008\nCDC, lesquels apportent également des fonds pour\nl’achat du VPO nécessaire aux campagnes de\nvaccination de masse et fournissent toute une\ngamme de compétences techniques et un appui en\nlaboratoire. Ils détachent en particulier du\npersonnel pour la surveillance de la maladie aux\nniveaux mondial, régional et national et pour les\nenquêtes sur les flambées, particulièrement dans\ndes régions situées à l’intérieur ou à proximité de\nzones exemptes de poliomyélite. Les CDC font\noffice de « détective viral » po",
      "truncated": true,
      "provenance": "ingested",
      "summary": {
        "status": "draft",
        "text": "Describes the US Centers for Disease Control and Prevention's support, including funding for OPV, staff for surveillance and outbreak investigations and advanced virological expertise to trace virus origins. It covers international development agencies such as those of Germany, Canada, the United States, Japan and the United Kingdom, which had given or pledged US$ 1.76 billion, 59% of all funds for 1985–2005. It also notes that the Bill & Melinda Gates Foundation is the largest donor after the Rotary Foundation, with US$ 75 million committed.",
        "state": "draft",
        "draftedBy": {
          "kind": "agent",
          "id": "claude-code",
          "model": "not-disclosed"
        },
        "draftedAt": "2026-11-11"
      }
    },
    {
      "id": "library/10665-42988/blocks/prose-page-041",
      "types": [
        "folio-assistant-core:Prose",
        "doco:Section"
      ],
      "kind": "prose",
      "title": "Page 41",
      "pageStart": 41,
      "pageEnd": 41,
      "target": "../sections/page-041.md",
      "narrative": null,
      "content": "39\nPLAN STRATEGIQUE DE L’INITIATIVE MONDIALE POUR L’ERADICATION DE LA POLIOMYELITE 2004-2008\nUnies ont également aidé l’Initiative en\ncollaborant avec la Banque mondiale à\nl’application d’un mécanisme financier de\nconversion de prêts en dons qui permettra\nd’acheter du vaccin antipoliomyélitique pour le\nNigéria et le Pakistan.\nBanques de développement et organismes\nmultilatéraux : Des institutions comme la\nBanque mondiale et la Banque interaméricaine de\nDéveloppement ont donné accès à un financement\nau niveau national en octroyant des prêts à des\nconditions de faveur. La Banque mondiale a\nd’aut",
      "truncated": true,
      "provenance": "ingested",
      "summary": {
        "status": "draft",
        "text": "Describes a loan buy-down mechanism set up by the World Bank with foundations and Rotary to purchase polio vaccine for Nigeria and Pakistan, concessional loans from development banks, and private-sector fundraising. It covers international humanitarian organizations, with Red Cross and Red Crescent societies supporting campaigns and volunteer mobilization and the ICRC facilitating access to conflict zones. It notes that NGOs such as the Albert B. Sabin Vaccine Institute, Médecins sans Frontières and Save the Children support advocacy and have reached children in conflict-affected countries.",
        "state": "draft",
        "draftedBy": {
          "kind": "agent",
          "id": "claude-code",
          "model": "not-disclosed"
        },
        "draftedAt": "2026-11-11"
      }
    },
    {
      "id": "library/10665-42988/blocks/prose-page-042",
      "types": [
        "folio-assistant-core:Prose",
        "doco:Section"
      ],
      "kind": "prose",
      "title": "Page 42",
      "pageStart": 42,
      "pageEnd": 42,
      "target": "../sections/page-042.md",
      "narrative": null,
      "content": "40\nPLAN STRATEGIQUE DE L’INITIATIVE MONDIALE POUR L’ERADICATION DE LA POLIOMYELITE 2004-2008\n6 . 5\nF a b r i c a n t s d e v a c c i n\nL’industrie du vaccin joue un rôle déterminant\ndans l’aide aux activités de vaccination\nsystématique et aux activités de vaccination\nsupplémentaires contre la poliomyélite en\nfournissant les quantités nécessaires de vaccin de\nqualité contrôlée. Les fabricants veillent à ce que\ndes quantités suffisantes de vaccin soient\ndisponibles au moment voulu en vérifiant que les\nplans de production et d’investissement pour le\ndéveloppement des capacités sont mis en œuvre a",
      "truncated": true,
      "provenance": "ingested",
      "summary": {
        "status": "draft",
        "text": "Describes the role of vaccine manufacturers in supplying enough quality-controlled polio vaccine on time, working with UNICEF and WHO on demand forecasts and production planning, and conducting research on products needed after certification.",
        "state": "draft",
        "draftedBy": {
          "kind": "agent",
          "id": "claude-code",
          "model": "not-disclosed"
        },
        "draftedAt": "2026-11-11"
      }
    },
    {
      "id": "library/10665-42988/blocks/prose-page-043",
      "types": [
        "folio-assistant-core:Prose",
        "doco:Section"
      ],
      "kind": "prose",
      "title": "Page 43",
      "pageStart": 43,
      "pageEnd": 43,
      "target": "../sections/page-043.md",
      "narrative": null,
      "content": "41\nPLAN STRATEGIQUE DE L’INITIATIVE MONDIALE POUR L’ERADICATION DE LA POLIOMYELITE 2004-2008\n2 0 0 9 e t a u - d e l à - l a\np h a s e d ’ a r r ê t d e l a\nv a c c i n a t i o n p a r l e V P O\nd a n s l e m o n d e\n7\nC\nOMPTE tenu de l’expérience de l’éradication\nde la variole et des risques associés à la\npoursuite de l’utilisation du VPO, il est évident\nqu’il faut prévoir un dosage d’activités\nd’éradication à long terme et de durée limitée\naprès la certification de l’éradication mondiale\n(date butoir : 2008). Les produits et politiques\nnécessaires pour cette phase de l’Initiative étant en\nco",
      "truncated": true,
      "provenance": "ingested",
      "summary": {
        "status": "draft",
        "text": "Opens the chapter on 2009 and beyond, the phase of stopping OPV worldwide, explaining that both long-term and time-limited activities will be needed after certification, though costs cannot yet be estimated. It describes long-term needs such as independent verification of poliovirus containment and management of monovalent OPV stockpiles. It outlines time-limited measures against vaccine-derived poliovirus, such as maintaining acute flaccid paralysis surveillance for at least two years after OPV cessation and possibly environmental sampling or pre-cessation campaigns.",
        "state": "draft",
        "draftedBy": {
          "kind": "agent",
          "id": "claude-code",
          "model": "not-disclosed"
        },
        "draftedAt": "2026-11-11"
      }
    },
    {
      "id": "library/10665-42988/blocks/prose-page-044",
      "types": [
        "folio-assistant-core:Prose",
        "doco:Section"
      ],
      "kind": "prose",
      "title": "Page 44",
      "pageStart": 44,
      "pageEnd": 44,
      "target": "../sections/page-044.md",
      "narrative": null,
      "content": "42\nPLAN STRATEGIQUE DE L’INITIATIVE MONDIALE POUR L’ERADICATION DE LA POLIOMYELITE 2004-2008\nfourniture de ces vaccins pour la vaccination\nsystématique, comme l’Alliance mondiale pour les\nvaccins et la vaccination, devront jouer dans cette\ndémarche un rôle central.\nPour ce qui est des ressources, les incidences\nde la phase d’arrêt de la vaccination par le VPO\ndans le monde seront déterminées compte tenu des\ntravaux visant à définir les produits et politiques\nappropriés pour cette période, comme on l’a vu au\ntitre de l’objectif Nº 3 du Plan stratégique de\nl'Initiative mondiale pour l’éradicatio",
      "truncated": true,
      "provenance": "ingested",
      "summary": {
        "status": "draft",
        "text": "Notes that partners supplying routine vaccines, such as GAVI, will be central to decisions on post-OPV vaccination, and that financial needs will depend on international decisions in 2005–2007 about OPV cessation, stockpiles and other polio vaccines.",
        "state": "draft",
        "draftedBy": {
          "kind": "agent",
          "id": "claude-code",
          "model": "not-disclosed"
        },
        "draftedAt": "2026-11-11"
      }
    },
    {
      "id": "library/10665-42988/blocks/prose-page-045",
      "types": [
        "folio-assistant-core:Prose",
        "doco:Section"
      ],
      "kind": "prose",
      "title": "Page 45",
      "pageStart": 45,
      "pageEnd": 45,
      "target": "../sections/page-045.md",
      "narrative": null,
      "content": "43\nGLOBAL POLIO ERADICATION INITIATIVE STRATEGIC PLAN 2004–2008\nPartenaires principaux de l’Initiative mondiale\npour l’éradication de la poliomyélite\nOrganisation mondiale de la Santé\nInitiative mondiale pour l’éradication de la poliomyélite\n20, avenue Appia\nCH-1211 Genève 27\nSuisse\nTéléphone : (41 22) 791 2111\nTélécopie : (41 22) 791 4193\nCourriel :  polioepi@who.int\nSite web : www.polioeradication.org\nOMS",
      "truncated": false,
      "provenance": "ingested",
      "summary": {
        "status": "draft",
        "text": "The back cover listing WHO as a spearheading partner of the Global Polio Eradication Initiative, with its Geneva address and contact details.",
        "state": "draft",
        "draftedBy": {
          "kind": "agent",
          "id": "claude-code",
          "model": "not-disclosed"
        },
        "draftedAt": "2026-11-11"
      }
    }
  ]
}
